Are Small-Cap Biotech Stocks Worth Watching? 2 Gaining Ground This Month
Are Small-Cap Biotech Stocks Part Of Your Strategy? Some say yes, some say no. Investors have mixed feelings on small-cap biotech stocks. In one breath, “They are too small.” But in the next, “They show some of the biggest potential.” At the end of the day, understand that even though small-cap biotechnology stocks are high risk, the events that fuel momentum have triggered immense opportunities.
1 Stock is Positioning to Disrupt a Billion Dollar Industry Creating Opportunity & Saving Lives
There have been more mass shootings this year in the United States than there have been days in the year. Over 330 mass shootings , to be exact. This is becoming a huge issue that is costing precious lives and could see billions of dollars spent to fix this situation. One company could be a major industry disruptor!
Biotech Stocks In Focus Amid New Wave Of Drug Delivery
Everyone looks to biotechnology stocks to change the world with novel treatments & breakthrough therapies. This is an amazing opportunity for companies to deliver promising outcomes for some of the world’s hardest to treat diseases. But one key thing most don’t remember to observe is the delivery itself. Drug delivery becomes critical to the success of its outcome. Obviously, the outcome is a successfully treated patient. If the delivery method is less than optimal, so to will be the results.